Video
Dr. Shoag and Dr. Spratt discuss SpaceOAR Center of Excellence distinction
Author(s):
“It's really the overall excellence of a multidisciplinary program focused on improving patient outcomes,” says Daniel E. Spratt, MD.
Video Player is loading.
In this video, Jonathan E. Shoag, MD, and Daniel E. Spratt, MD, discuss University Hospitals Cleveland Medical Center being named the first SpaceOAR Hydrogel Center of Excellence as well as the importance of multidisciplinary care in treating prostate cancer. Shoag is a urologist at University Hospitals and an assistant professor of urology at Case Western Reserve University School of Medicine, and Spratt is chair of Radiation Oncology at UH Cleveland Medical Center and a professor at Case Western Reserve University School of Medicine.
Related Videos
Study results show CVAC 2.0 is safe, efficacious for wide range of kidney stones
De novo metastatic prostate cancer: Understanding Biden’s prognosis and treatment
Geoffrey Sonn, MD, on an AI risk mapping tool to predict seminal vesicle invasion
Alternative treatments and patient communication for genitourinary syndrome of menopause
Amir Patel, MD, on ureteral strictures following holmium vs TFL laser lithotripsy
Prostate cancer screening: Expert weighs in after Biden's diagnosis
Sarah Razavi, MD, discusses the physical toll of ureteroscopy on urologists
Clinical Outcomes of Ultra-Low PSA Responses in Patients With mHSPC Receiving Darolutamide Plus ADT
Post Hoc Analysis of ARANOTE; Ultra-Low PSA Responses
Study results affirm effectiveness of evolving prostate cancer therapies
Related Content
